Skip to search formSkip to main contentSkip to account menu

SR 121566

Known as: SR 121566A, SR-121566A, SR121566 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Summary.  Background: Platelets are hyperactive in Type 2 diabetes mellitus (T2DM), and antiplatelet treatment with glycoprotein… 
2003
2003
Summary. The action of clopidogrel on platelet receptors was analysed using platelets obtained from 11 healthy volunteers given… 
2001
2001
Summary SR121566 is a new synthetic agent which inhibits the binding of fibrinogen to activated platelets, and platelet… 
2001
2001
SR 121566A represents a peptidomimetic glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitor 3-[N-{4-[4-(aminoiminomethyl)phenyl ]-1 ,3… 
2000
2000
Since results of recent clinical trial, performed in patients suffering from acute coronary syndromes, suggested that aspirin… 
1999
1999
We report the results from an interspecies comparison of the antiplatelet, antithrombotic, and hemorrhagic actions of SR 121566A… 
1998
1998
The effects of SR121566, a new inhibitor of the glycoprotein (GP) IIb/IIIa complex on platelet activation and platelet-leukocyte…